1. Remdesivir for the Treatment of COVID-19: A Narrative Review

   • Patrick O. Godwin
   • Bryan Polsonetti
   • Thomas F. Oppelt

   Review Open access 09 January 2024 Pages: 1 - 19

2. Navigating the Complex Landscape of Ebola Infection Treatment: A Review of Emerging Pharmacological Approaches

   • Francisca Almeida-Pinto
   • Rui Pinto
   • João Rocha

   Review Open access 19 January 2024 Pages: 21 - 55

   

3. Safety and Immunogenicity of a Recombinant Two-Component SARS-CoV-2 Protein Vaccine: Randomized, Double-Blind, Placebo-Controlled Phase I and Phase II Studies

   • Chris Wynne
   • Abundio Balgos
   • Yong Liu

   Original Research Open access 16 December 2023 Pages: 57 - 78

   

4. Global Prevalence of Varicella-Associated Complications: A Systematic Review and Meta-Analysis

   • Hiral Anil Shah
   • Anne Meiwald
   • Nicolas Jamet

   Original Research Open access 19 December 2023 Pages: 79 - 103

   

5. Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive Protein

   • Konstantina Iliopoulou
   • Panagiotis Koufargyris
   • Evangelos J. Giamarellos-Bourboulis

   Original Research Open access 19 December 2023 Pages: 105 - 119

   

6. Incidence and Burden of Herpes Zoster in Sweden: A Regional Population-Based Register Study

   • Emma Södergren
   • Kristina Mårdberg
   • Patrik Stäck

   Original Research Open access 09 January 2024 Pages: 121 - 140

   

7. Clinical Efficacy and Safety of Colistin Sulfate in the Treatment of Carbapenem-Resistant Organism Infections in Patients with Hematological Diseases

   • Yuanbing Wu
   • Shanshan Jiang
   • Xiaohui Hu

   Original Research Open access 11 January 2024 Pages: 141 - 154

   

8. Nirmatrelvir/Ritonavir Utilization for the Treatment of Non-hospitalized Adults with COVID-19 in the National Veterans Affairs (VA) Healthcare System

   • Haley J. Appaneal
   • Kerry L. LaPlante
   • Aisling R. Caffrey

   Original Research Open access 13 January 2024 Pages: 155 - 172

   

9. A First-in-Human Randomized Study to Assess the Safety, Tolerability, Pharmacokinetics, and Neutralization Profile of Two Investigational Long-Acting Anti-SARS-CoV-2 Monoclonal Antibodies

   • Norman Moullan
   • Josephat Asiago
   • Prakash Bhuyan

   Original Research Open access 14 January 2024 Pages: 173 - 187

   

10. Safety and Effectiveness of Molnupiravir in Japanese Patients with COVID-19: Final Report of Post-marketing Surveillance in Japan

    • Shohei Shinozaki
    • Asuka Watanabe
    • Shinichiroh Maekawa

    Original Research Open access 17 January 2024 Pages: 189 - 205

    

11. Rates of Lower Respiratory Tract Illness in US Adults by Age and Comorbidity Profile

    • Derek Weycker
    • Ahuva Averin
    • Mark Rozenbaum

    Original Research Open access 18 January 2024 Pages: 207 - 220

    

12. Efficacy and Health-Related Quality of Life Impact of Fecal Microbiota, Live-jslm: A Post Hoc Analysis of PUNCH CD3 Patients at First Recurrence of Clostridioides difficile Infection

    • Paul Feuerstadt
    • Jessica R. Allegretti
    • Sahil Khanna

    Original Research Open access 18 January 2024 Pages: 221 - 236

    

13. A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol

    • Beatriz Arns
    • Jaqueline Driemeyer C. Horvath
    • Alexandre P. Zavascki

    Study Protocol Open access 16 December 2023 Pages: 237 - 250